abstract |
A novel compound is provided. The present invention relates to novel compounds that exhibit high affinity for cocaine receptors in the brain, particularly dopamine and serotonin transporter sites. The present invention can be used as an imaging agent or a pharmaceutical agent in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases. [Selection figure] None |